| |
| Issue |
Title |
| |
| No 4 (2024) |
Experimental models of aging |
Abstract
PDF (Rus)
|
|
A. A. Garanin, O. A. Gromova, T. E. Bogacheva |
| |
| No 4 (2024) |
Dimeric dipeptide mimetics of BDNF loop 4 are potential antidepressants with novel mechanisms of action |
Abstract
PDF (Rus)
|
|
T. A. Gudasheva, P. Yu. Povarnina, A. V. Tarasyuk, V. P. Zherdev, A. D. Durnev |
| |
| No 3 (2024) |
Senesens. Heart. Senotherapy |
Abstract
PDF (Rus)
|
|
S. A. Kryzhanovskii, M. B. Vititnova |
| |
| No 3 (2021) |
Perspective for the use of adamantane-type drugs for the treatment of cerebrovascular and cardiovascular diseases |
Abstract
PDF (Rus)
|
|
D. A. Abaimov, A. A. Shabalina |
| |
| No 3 (2021) |
Organizing of pharmacokinetic investigations |
Abstract
PDF (Rus)
|
|
I. I. Miroshnichenko, O. Y. Kravtsova |
| |
| No 4 (2020) |
Pharmacokinetic relationships in psychotropic drugs effects |
Abstract
PDF (Rus)
|
|
G. B. Kolyvanov, A. A. Litvin, R. V. Shevchenko, S. Yu. Raskin, P. O. Bochkov, V. P. Zherdev |
| |
| No 3 (2020) |
Statistical processing of pharmacological experiments results measured in ordinal and quantitative scales, if it is impossible to analyze using parametric methods |
Abstract
PDF (Rus)
|
|
I. B. Tsorin |
| |
| No 4 (2019) |
Epac signaling protein ligands as tools for studying their biological activity and creating new original drugs |
Abstract
PDF (Rus)
|
|
G. V. Mokrov, T. D. Nikiforova, S. A. Kryzhanovskiy |
| |
| No 4 (2018) |
Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug |
Abstract
PDF (Rus)
|
|
G. V. Mokrov, O. A. Deeva, M. A. Yarkova, T. A. Gudasheva, S. B. Seredenin |
| |
| No 2 (2019) |
Matrix metalloproteinases and their inhibitors |
Abstract
PDF (Rus)
|
|
O. S. Grigorkevich, G. V. Mokrov, L. Yu. Kosova |
| |
| No 3 (2019) |
Statistical processing of qualitative (nominal) data in pharmacological research |
Abstract
PDF (Rus)
|
|
I. B. Tsorin |
| |
| 1 - 11 of 11 Items |
|
